This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Cryptolepis sanguinolenta
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
West African climber vine used in Ghana and neighboring countries as the primary herbal treatment for malaria, containing powerful alkaloids.
West African climber vine used in Ghana and neighboring countries as the primary herbal treatment for malaria, containing powerful alkaloids. Key active compounds include cryptolepine, quindoline, neocryptolepine.
cryptolepine, along with quindoline and neocryptolepine, are the primary bioactive compounds in Cryptolepis Sanguinolenta. These compounds modulates NF-κB and COX-2 inflammatory pathways, disrupts microbial cell membranes and inhibits pathogen growth.
Antiplasmodial
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Antimicrobial
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Antidiabetic
Anti-inflammatory
Malaria
Based on traditional use; clinical evidence limited
Fever
Based on traditional use; clinical evidence limited
Infections
Based on traditional use; clinical evidence limited
Diarrhea
Based on traditional use; clinical evidence limited
Found an error or have a correction for Cryptolepis Sanguinolenta?
Report an Issue →